中国药物应用与监测
中國藥物應用與鑑測
중국약물응용여감측
CHINESE JOURNAL OF DRUG APPLICATION AND MONITORING
2014年
2期
111-114
,共4页
李昱霖%梁志欣%王彬%朱曼%骆海伦%陈良安%佘丹阳
李昱霖%樑誌訢%王彬%硃曼%駱海倫%陳良安%佘丹暘
리욱림%량지흔%왕빈%주만%락해륜%진량안%사단양
替加环素%药品不良反应%低血糖
替加環素%藥品不良反應%低血糖
체가배소%약품불량반응%저혈당
Tigecycline%Adverse drug reaction%Hypoglycemia
目的:提高对替加环素不良反应的认识,为临床合理用药提供参考。方法:通过检索文献,对替加环素不良反应病例中患者一般情况、原患疾病、不良反应类型、不良反应发生时间、治疗方法及转归等进行分析,同时报道1例使用替加环素后引起低血糖反应患者的诊疗过程,并结合文献进行分析。结果:共检索出10例替加环素不良反应的个案报道,其中胰腺炎8例,腹泻1例,凝血功能异常1例。本文报道的1例78岁男性患者诊断为重症肺炎、慢性阻塞性肺疾病、肺间质纤维化,机械通气过程中,痰培养多次为多重耐药鲍曼不动杆菌,在使用替加环素静脉滴注后出现顽固性低血糖。结论:应用替加环素时,应高度警惕其不良反应的发生,确保安全用药。
目的:提高對替加環素不良反應的認識,為臨床閤理用藥提供參攷。方法:通過檢索文獻,對替加環素不良反應病例中患者一般情況、原患疾病、不良反應類型、不良反應髮生時間、治療方法及轉歸等進行分析,同時報道1例使用替加環素後引起低血糖反應患者的診療過程,併結閤文獻進行分析。結果:共檢索齣10例替加環素不良反應的箇案報道,其中胰腺炎8例,腹瀉1例,凝血功能異常1例。本文報道的1例78歲男性患者診斷為重癥肺炎、慢性阻塞性肺疾病、肺間質纖維化,機械通氣過程中,痰培養多次為多重耐藥鮑曼不動桿菌,在使用替加環素靜脈滴註後齣現頑固性低血糖。結論:應用替加環素時,應高度警惕其不良反應的髮生,確保安全用藥。
목적:제고대체가배소불량반응적인식,위림상합리용약제공삼고。방법:통과검색문헌,대체가배소불량반응병례중환자일반정황、원환질병、불량반응류형、불량반응발생시간、치료방법급전귀등진행분석,동시보도1례사용체가배소후인기저혈당반응환자적진료과정,병결합문헌진행분석。결과:공검색출10례체가배소불량반응적개안보도,기중이선염8례,복사1례,응혈공능이상1례。본문보도적1례78세남성환자진단위중증폐염、만성조새성폐질병、폐간질섬유화,궤계통기과정중,담배양다차위다중내약포만불동간균,재사용체가배소정맥적주후출현완고성저혈당。결론:응용체가배소시,응고도경척기불량반응적발생,학보안전용약。
Objective: To pay more attention to the adverse drug reactions (ADRs) induced by tigecycline and provide references for rational use of drugs. Methods:By reviewing the literatures, the ADRs induced by tigecyline were analyzed in respect of general data, primary disease of the patients, types of ADRs, occurrence time, therapeutic method, prognosis, etc. Meanwhile, a case of tigecycline-induced hypoglycemia was reported. Results: Ten ADRs cases induced by tigecycline were collected. Eight cases of them were pancreatitis, one case of diarrhea, one case of coagulation disorder. A 78-year-old male patient was diagnosed as severe pneumonia, chronic obstructive pulmonary disease, and pulmonary interstitial ifbrosis developing persistent hypoglycemia after intravenous infusion of tigecycline. During the mechanical ventilation, the result of sputum culture was multi-drugs resistant Acinetobacter Bauman. Conclusion:More attention should be paid to adverse events induced by tigecycline to ensure the safety of drug use in clinic.